| Target | CDK2 |
|---|
| Product Type | Antibody |
|---|
| Application | WB |
|---|
| Clonality | Monoclonal |
|---|
| Conjugate | unconjugated |
|---|
| Isotype | IgG |
|---|
| Immunogen | A synthetic peptide corresponding to a sequence within amino acids 199-298 of human CDK2 (P24941). |
|---|
| Host Species | Rabbit |
|---|
| Species Reactivity | Human, Mouse, Rat |
|---|
| Formulation | PBS with 0.02% sodium azide,0.05% BSA,50% glycerol |
|---|
| Research Area | Cancer, Immunology, Epigenetics |
|---|
| Description/Background | <p>This gene encodes a member of a family of serine/threonine protein kinases that participate in cell cycle regulation. The encoded protein is the catalytic subunit of the cyclin-dependent protein kinase complex, which regulates progression through the cell cycle. Activity of this protein is especially critical during the G1 to S phase transition. This Protein A Affinity purificationssociates with and regulated by other subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A), and p27Kip1 (CDKN1B). Alternative splicing results in multiple transcript variants.</p> |
|---|
| Protocols | WB |
|---|
| Molecular Weight | 34kDa |
|---|
| Concentration | 1.2 mg/mL |
|---|
| Purity | Affinity purification |
|---|
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
|---|
